Treat COVID-19 earlier to save lives, advise experts

Washington D.C. [USA], June 17 (ANI): Infectious disease experts are advocating for earlier actions to reduce...

COVID-19 cure possible through Ayurveda, Patanjali case study...

Haridwar (Uttarakhand) [India], June 13 (ANI): Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, on...

Zydus signs licensing agreement with Gilead to manufacture...

Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing...

Centre brings fresh rules for import of unapproved new drug...

New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new...

'First-ever in modern Indian medicine': CSIR DG hails...

New Delhi [India], June 6 (ANI): Clinical trials of the plant-derived drug, ACQH, to treat COVID-19 patients that...

Women, minorities lacking in research and clinical trials for...

Washington D.C. [USA], May 31 (ANI): The findings of a recent study show that over the past decade -- women and...

Study finds women, minorities lacking in research and...

Washington D.C. [USA], May 28 (ANI): Over the past decade, women and minorities, particularly African Americans,...

Lancet study is not randomised clinical trial, only analysis...

New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per...

India disagrees with WHO suspension of HCQ usage, sends...

New Delhi [India], May 26 (ANI): Health Ministry of India has written to the World Health Organisation (WHO) after...

Hydroxychloroquine --promoted by Trump as Covid 'game...

Washington D.C. [USA], May 17 (ANI): Clinical trials of the anti-malarial drug or hydroxychloroquine, which gained...

COVID-19: Cipla enters into licensing pact with Gilead to...

Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a...

Glenmark begins phase 3 of clinical trials on antiviral...

Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in...